|
Verzögert
NSE India S.E.
08:39:30 02.09.2026
|
% 5 Tage | Veränd. 1. Jan. | ||
| 5’220.00 INR | -1.51% |
|
-1.61% | -5.24% |
| 14.08. | Alkem Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026 | |
| 14.08. | Alkem Laboratories Limited legt Ergebniszahlen für das erste Quartal zum 30. Juni 2026 vor | CI |
ETFs investiert in Alkem Laboratories Limited
| Name | % 1. Jan. | Gewichtung | Volumen | |
|---|---|---|---|---|
 | +12.36% | -.--% | 27 154 M€ | |
| +21.19% | -.--% | 9 273 M€ | |
| -2.28% | -.--% | 21 M€ | |
| +7.96% | -.--% | 37 M€ | |
| +11.17% | -.--% | 67 M€ | |
| +21.01% | 0.43% | 180 M€ | |
| -7.03% | 0.3% | 99 M€ | |
| -8.79% | 0.22% | 2 M€ | |
| -8.27% | 0.2% | 6 661 M€ | |
| +27.97% | 0.2% | 10 M€ | |
| +29.92% | 0.2% | 38 M€ | |
| +29.54% | 0.2% | 247 M€ | |
| -9.57% | 0.17% | 5 254 M€ | |
| -7.38% | 0.16% | 5 M€ | |
| -17.87% | 0.15% | 108 M€ | |
| -7.85% | 0.13% | 2 692 M€ | |
| -6.15% | 0.13% | 2 189 M€ | |
| -10.42% | 0.12% | 48 M€ | |
| +23.94% | 0.11% | 42 M€ | |
| +24.91% | 0.11% | 4 366 M€ | |
| +29.33% | 0.09% | 148 M€ | |
| +49.66% | 0.07% | 794 M€ | |
| -3.79% | 0.07% | 44 M€ | |
| +63.29% | 0.06% | 173 M€ | |
| -7.49% | 0.06% | 77 M€ | |
| -.--% | 0.04% | 7 M€ | |
| +13.71% | 0.04% | 535 M€ | |
| +34.14% | 0.04% | 168 M€ | |
| +26.43% | 0.04% | 8 289 M€ | |
| +34.97% | 0.04% | 1 049 M€ | |
| +34.87% | 0.04% | 24 558 M€ | |
| +36.32% | 0.04% | 103 M€ | |
| +20.11% | 0.04% | 10 M€ | |
| +21.25% | 0.04% | 859 M€ | |
| -.--% | 0.04% | 11 M€ | |
| +22.66% | 0.03% | 1 699 M€ | |
| +21.54% | 0.03% | 268 M€ | |
| +24.02% | 0.03% | 872 M€ | |
| +21.30% | 0.03% | 2 106 M€ |
Beschäftigte
19’346
Sektor
Pharmazeutika
- Börse
- Aktien
- A2ACU0 Aktie
- ETFs Alkem Laboratories Limited
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
